| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Hectorol (Doxercalciferol) Capsules, 2.5 mcg, Bone Care International NDA 20-862 6/9/99 6/11/99 6/11/99 6/29/00 Hectorol Indication:For the reduction of elevated iPTH levels in the management of secondary hyperparathyroidism in patients undergoing chronic renal dialysis. Hectorol IV, Bone Care International NDA 21-027 Hectorol (doxercalciferol) Injection, Bone Care International |
|
© 2009 Betterchem.com
|